Physician

Abdulrazak Fisal Alchakaki, M.D

According to 2025 Medicare claims, Abdulrazak Alchakaki, M.D (NPI: 1407088123) practices pulmonary disease in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is MICHIGAN LUNG & SLEEP ASSOCIATION PC (NPI: 1265010227; TIN: 852732788) and primary practice location at 48134-1522. Alchakaki is affiliated with the CCA ACO LLC (ACO ID: A2198), participating under the MSSP model.

Alchakaki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 667 traditional Medicare patients, billed 2,745 HCPCS/CPT codes, and received $179,989 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,186 prescription claims across 293 beneficiaries totaling $829,056 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 835 claims. Open Payments data shows 10 records totaling $2,736. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $80,214 to $179,989. Similarly, Part D prescription costs have risen steadily, from $11,276 to $829,056. For DME billing, reported payments moved sharply higher in recent years, from $1,372 to $59,915.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	319	968	$80,214
2016	96	141	$12,092
2017	126	185	$16,446
2018	260	763	$63,463
2019	656	2,011	$165,672
2020	739	2,579	$221,479
2021	737	2,403	$225,592
2022	751	2,812	$232,401
2023	648	2,598	$186,497
2024	667	2,745	$179,989

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	72	229	$11,276
2016	49	147	$11,420
2017	56	199	$30,261
2018	38	81	$13,255
2019	96	392	$105,642
2020	139	714	$240,087
2021	176	749	$272,726
2022	192	809	$395,589
2023	248	991	$526,064
2024	293	1,186	$829,056

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	44	$987
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	136	$32,296
2020	23	258	$37,990
2021	54	600	$51,070
2022	56	490	$45,008
2023	154	758	$85,858
2024	166	835	$73,749

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	162	168	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	147	218	$95
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	176	312	$93
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	347	790	$61
94729	Test to examine how well the lungs exchange gases	94	103	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	339	15,090	$307,572
Dupixent Pen	Dupilumab	31	952	$125,153
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	80	4,320	$63,840
Nucala	Mepolizumab	13	364	$45,564
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	58	2,580	$39,052

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	24	$24,473
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	22	$16,690
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	17	127	$10,017
E0601	Continuous positive airway pressure (cpap) device	Y	18	102	$2,963
E1392	Portable oxygen concentrator, rental	Y	N/R	68	$2,335

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$2,736	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdulrazak Fisal Alchakaki, M.D?

Tedicare shows public-source Medicare data for Abdulrazak Fisal Alchakaki, M.D (NPI 1407088123), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdulrazak Fisal Alchakaki, M.D have ACO affiliation data?

Abdulrazak Fisal Alchakaki, M.D is shown with ACO affiliation data for CCA ACO LLC (MSSP, ACO ID A2198).

What billing organization is linked to Abdulrazak Fisal Alchakaki, M.D?

Abdulrazak Fisal Alchakaki, M.D is linked to MICHIGAN LUNG & SLEEP ASSOCIATION PC (billing NPI 1265010227) in the available physician profile data.

Does Abdulrazak Fisal Alchakaki, M.D have Open Payments data?

Abdulrazak Fisal Alchakaki, M.D has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.